Viatris Inc: Drug Recall
Recall #D-0058-2023 · 10/07/2022
Class I: Dangerous
Recall Details
- Recall Number
- D-0058-2023
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Viatris Inc
- Status
- Terminated
- Date Initiated
- 10/07/2022
- Location
- Canonsburg, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22400 syringes
Reason for Recall
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Product Description
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).
Distribution Pattern
Nationwide in the USA
Other Recalls by Viatris Inc
- Class II: Risk 12/23/2024
- Class II: Risk 12/23/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.